Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: Protective Effect of Ulinastatin and Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI) [NA]

View source ↗

Summary

A clinical trial evaluating whether ulinastatin and thymosin α1 can mitigate immune dysregulation and organ dysfunction after acute aortic dissection surgery; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thymosin alpha-1 (thymosin alpha-1)
  • Ulinastatin (ulinastatin)

Snippet

Sponsor: Nanjing Medical University | Conditions: Aortic Dissection, Aortic Dissection Aneurysm | NA | Status: ENROLLING_BY_INVITATION